2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES

The present invention relates to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds of general formula (I) or (Ib), to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WENGNER Antje-Margret, BRIEM Hans, LIENAU Philip, MOOSMAYER Dieter, KOPPITZ Marcus, SIEMEISTER Gerhard, VON NUSSBAUM Franz, GRUDZINSKA-GOEBEL Joanna, SCHICK Hans, LEFRANC Julien, EBERSPACHER Uwe, LUCKING Ulrich, EIS Knut, BADER Benjamin, WORTMANN Lars, BONE Wilhelm
Format: Patent
Sprache:eng ; slv
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator WENGNER Antje-Margret
BRIEM Hans
LIENAU Philip
MOOSMAYER Dieter
KOPPITZ Marcus
SIEMEISTER Gerhard
VON NUSSBAUM Franz
GRUDZINSKA-GOEBEL Joanna
SCHICK Hans
LEFRANC Julien
EBERSPACHER Uwe
LUCKING Ulrich
EIS Knut
BADER Benjamin
WORTMANN Lars
BONE Wilhelm
description The present invention relates to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds of general formula (I) or (Ib), to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative disease as a sole agent or in combination with other active ingredients.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SI3395818TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SI3395818TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SI3395818TT13</originalsourceid><addsrcrecordid>eNrjZFA10tXw9Q8K8PD38fTTNdGN9NHUNdQx1_VzDPAI8YgM8nTx9HMN5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8cGexsaWphaGFiEhhsbEqAEAb7sjTw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES</title><source>esp@cenet</source><creator>WENGNER Antje-Margret ; BRIEM Hans ; LIENAU Philip ; MOOSMAYER Dieter ; KOPPITZ Marcus ; SIEMEISTER Gerhard ; VON NUSSBAUM Franz ; GRUDZINSKA-GOEBEL Joanna ; SCHICK Hans ; LEFRANC Julien ; EBERSPACHER Uwe ; LUCKING Ulrich ; EIS Knut ; BADER Benjamin ; WORTMANN Lars ; BONE Wilhelm</creator><creatorcontrib>WENGNER Antje-Margret ; BRIEM Hans ; LIENAU Philip ; MOOSMAYER Dieter ; KOPPITZ Marcus ; SIEMEISTER Gerhard ; VON NUSSBAUM Franz ; GRUDZINSKA-GOEBEL Joanna ; SCHICK Hans ; LEFRANC Julien ; EBERSPACHER Uwe ; LUCKING Ulrich ; EIS Knut ; BADER Benjamin ; WORTMANN Lars ; BONE Wilhelm</creatorcontrib><description>The present invention relates to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds of general formula (I) or (Ib), to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative disease as a sole agent or in combination with other active ingredients.</description><language>eng ; slv</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220131&amp;DB=EPODOC&amp;CC=SI&amp;NR=3395818T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220131&amp;DB=EPODOC&amp;CC=SI&amp;NR=3395818T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WENGNER Antje-Margret</creatorcontrib><creatorcontrib>BRIEM Hans</creatorcontrib><creatorcontrib>LIENAU Philip</creatorcontrib><creatorcontrib>MOOSMAYER Dieter</creatorcontrib><creatorcontrib>KOPPITZ Marcus</creatorcontrib><creatorcontrib>SIEMEISTER Gerhard</creatorcontrib><creatorcontrib>VON NUSSBAUM Franz</creatorcontrib><creatorcontrib>GRUDZINSKA-GOEBEL Joanna</creatorcontrib><creatorcontrib>SCHICK Hans</creatorcontrib><creatorcontrib>LEFRANC Julien</creatorcontrib><creatorcontrib>EBERSPACHER Uwe</creatorcontrib><creatorcontrib>LUCKING Ulrich</creatorcontrib><creatorcontrib>EIS Knut</creatorcontrib><creatorcontrib>BADER Benjamin</creatorcontrib><creatorcontrib>WORTMANN Lars</creatorcontrib><creatorcontrib>BONE Wilhelm</creatorcontrib><title>2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES</title><description>The present invention relates to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds of general formula (I) or (Ib), to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative disease as a sole agent or in combination with other active ingredients.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFA10tXw9Q8K8PD38fTTNdGN9NHUNdQx1_VzDPAI8YgM8nTx9HMN5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8cGexsaWphaGFiEhhsbEqAEAb7sjTw</recordid><startdate>20220131</startdate><enddate>20220131</enddate><creator>WENGNER Antje-Margret</creator><creator>BRIEM Hans</creator><creator>LIENAU Philip</creator><creator>MOOSMAYER Dieter</creator><creator>KOPPITZ Marcus</creator><creator>SIEMEISTER Gerhard</creator><creator>VON NUSSBAUM Franz</creator><creator>GRUDZINSKA-GOEBEL Joanna</creator><creator>SCHICK Hans</creator><creator>LEFRANC Julien</creator><creator>EBERSPACHER Uwe</creator><creator>LUCKING Ulrich</creator><creator>EIS Knut</creator><creator>BADER Benjamin</creator><creator>WORTMANN Lars</creator><creator>BONE Wilhelm</creator><scope>EVB</scope></search><sort><creationdate>20220131</creationdate><title>2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES</title><author>WENGNER Antje-Margret ; BRIEM Hans ; LIENAU Philip ; MOOSMAYER Dieter ; KOPPITZ Marcus ; SIEMEISTER Gerhard ; VON NUSSBAUM Franz ; GRUDZINSKA-GOEBEL Joanna ; SCHICK Hans ; LEFRANC Julien ; EBERSPACHER Uwe ; LUCKING Ulrich ; EIS Knut ; BADER Benjamin ; WORTMANN Lars ; BONE Wilhelm</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SI3395818TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; slv</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>WENGNER Antje-Margret</creatorcontrib><creatorcontrib>BRIEM Hans</creatorcontrib><creatorcontrib>LIENAU Philip</creatorcontrib><creatorcontrib>MOOSMAYER Dieter</creatorcontrib><creatorcontrib>KOPPITZ Marcus</creatorcontrib><creatorcontrib>SIEMEISTER Gerhard</creatorcontrib><creatorcontrib>VON NUSSBAUM Franz</creatorcontrib><creatorcontrib>GRUDZINSKA-GOEBEL Joanna</creatorcontrib><creatorcontrib>SCHICK Hans</creatorcontrib><creatorcontrib>LEFRANC Julien</creatorcontrib><creatorcontrib>EBERSPACHER Uwe</creatorcontrib><creatorcontrib>LUCKING Ulrich</creatorcontrib><creatorcontrib>EIS Knut</creatorcontrib><creatorcontrib>BADER Benjamin</creatorcontrib><creatorcontrib>WORTMANN Lars</creatorcontrib><creatorcontrib>BONE Wilhelm</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WENGNER Antje-Margret</au><au>BRIEM Hans</au><au>LIENAU Philip</au><au>MOOSMAYER Dieter</au><au>KOPPITZ Marcus</au><au>SIEMEISTER Gerhard</au><au>VON NUSSBAUM Franz</au><au>GRUDZINSKA-GOEBEL Joanna</au><au>SCHICK Hans</au><au>LEFRANC Julien</au><au>EBERSPACHER Uwe</au><au>LUCKING Ulrich</au><au>EIS Knut</au><au>BADER Benjamin</au><au>WORTMANN Lars</au><au>BONE Wilhelm</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES</title><date>2022-01-31</date><risdate>2022</risdate><abstract>The present invention relates to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds of general formula (I) or (Ib), to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative disease as a sole agent or in combination with other active ingredients.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; slv
recordid cdi_epo_espacenet_SI3395818TT1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T08%3A13%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WENGNER%20Antje-Margret&rft.date=2022-01-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESI3395818TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true